乌鸦传媒

<乌鸦传媒 class='mpt-top_cat_title'>Oncology/Hematology >

Renal Cell Carcinoma

News, opinions and meeting coverage in oncology/hematology.

<乌鸦传媒>High Suicide Rate in Urologic Ca Patients

Four to five times higher in British study

<乌鸦传媒>mRCC Agents: Similar Outcomes in Cross-Trial Comparison

PFS, OS not that different between axitinib and cabozantinib

<乌鸦传媒>Stool Bacteria May Influence Tx Response in RCC

Also, antibiotic use just before treatment may impact disease progression

<乌鸦传媒>Kidney Cancer Patients Take to Twitter for Support, Info

Social media platform may be useful for trial recruitment, researchers say

<乌鸦传媒>Insurance Status Linked to mRCC Survival Odds

Patients with private insurance get better treatment, have better outcomes

<乌鸦传媒>AUA 2017: New Sessions, Encores, Variety

'Something for everybody' in urology

<乌鸦传媒>MSK Cancer Alliance: Mainly About Medicine

Bi-directional relationship strengthens regional cancer care

<乌鸦传媒>Cancer Drugs' Benefit Continues After Drug Stopped

Response for as long as 20 months after PD-1/PD-L1 stopped

<乌鸦传媒>Antibiotics May Damper Effect of PD-1/PD-L1 Blockade

Worse PFS in metastatic renal cell carcinoma

<乌鸦传媒>Slippery Slope: A Targeted Therapy That Misses the Mark?

Afinitor racks up FDA approvals, but where is the evidence?

<乌鸦传媒>Clinical Focus In Renal Cell Carcinoma: Clues from Gene Studies

Mutations in four genes appear to play a key role in the origin of renal cell carcinoma.

<乌鸦传媒>Medicare to Pay for More FDG-PET Scans

WASHINGTON -- Up to three scans using 18F-fluorodeoxyglucose-enhanced positron emission tomography technology can be covered by Medicare for oncology treatment planning, the Centers for Medicare and Medicaid Services said.